The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways

Objective GuizhiFulingWan (GFW) has been reported to be effective against polycystic ovary syndrome (PCOS) by possessing oxidative stress and inflammation which related to PI3K/AKT/NF-κB, Nrf2/HO-1 pathway. This study aims to probe the effects and mechanisms of GFW combined with rosiglitazone on PCO...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yongju Ye, Weimei Zhou, Yuefang Ren, Jiali Lu, Aixue Chen, Ruiying Jin, Feilan Xuan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2023-12-01
Schriftenreihe:	Gynecological Endocrinology
Schlagworte:	Polycystic ovary syndrome guizhi fuling wan rosiglitazone PI3K/AKT/NF-κB pathway Nrf2/HO-1 pathway
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/09513590.2023.2254848
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!